-+ 0.00%
-+ 0.00%
-+ 0.00%

Q32 BIO TO REPORT 36-WEEK TOPLINE RESULTS FROM PART B OF SIGNAL-AA CLINICAL TRIAL OF BEMPIKIBART IN ALOPECIA AREATA ON JULY 13, 2026

Reuters·07/10/2026 20:05:01

Please log in to view news